Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Binocular UIVA (logMAR)

From: Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients

Binocular UIVA Group A
Bilateral Supracor
Group B
Supracor + Standard LASIK
Group C
Supracor + Untreated
One way ANOVA (p value)
Pre OP 0.40 ± 0.00 (20/50) 0.40 ± 0.00 (20/50) 0.30 ± 0.11 (20/40) 0.00
1 Month −0.02 ± 0.09 (20/20) −0.01 ± 0.07 (20/20) 0.05 ± 0.06 (20/20) 0.053
3 Months −0.05 ± 0.07 (20/20) 0.04 ± 0.10 (20/20) 0.00 ± 0.11 (20/20) 0.13
6 Months −0.10 ± 0.08 (20/16) 0.00 ± 0.05 (20/20) −0.10 ± 0.17 (20/16) 0.19